National Drug Abuse Treatment

  PROTOCOL NIDA-CTN-0035-Ot


Access to HIV and Hepatitis Screening and Care Among Ethnic Minority Drug Users In and Out of Drug Treatment

Carmen Masson, PhD
Lead Investigator

Associate Adjunct Professor, Psychiatry
University of Calfornia, San Francisco
1001 Potrero Ave.
SFGH Building 20, Ward 21
San Francisco, CA 94110
carmen.masson@ucsf.edu


This study is in collaboration with the NIH National Center for Minority Health and Health Disparities and will be conducted in the California/Arizona Node. The primary goal of this study is to identify barriers and facilitators to HIV and hepatitis C screening and treatment among ethnic minority drug users. Using a combination of structured survey and qualitative focus group methods, researchers will interview drug users in and out of drug abuse treatment about their previous experiences in accessing HIV and HCV screening and treatment services. They will interview HIV and/or HCV infected drug users recruited from three settings: methadone maintenance, HIV primary care, and syringe exchange programs. Survey and focus group topics will address past and current experiences in accessing HIV and HCV screening and treatment, risk behaviors, perceptions of treatment settings and providers, lifetime substance use and past-30-day use, past and current motivation for screening and treatment, and resource and structural barriers.

  LATEST PUBLICATIONS AND DATA

Find publications in the Library about Protocol CTN-0035-Ot

NODES & CTPs SEARCH LINK
California/Arizona (Lead) search www
OTHER RESOURCES
NIDA protocol page (coming soon!)


Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 5/2010 -- http://ctndisseminationlibrary.org/protocols/ctn0035.htm
info@ctndisseminationlibrary.org